Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2014-05-08
DOI
10.1155/2014/963507
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel
- (2013) Saeed Manoochehri et al. DARU-Journal of Pharmaceutical Sciences
- Synthesis, characterization, and antitumor evaluation of the albumin–SN38 conjugate
- (2012) Yuqin Yao et al. ANTI-CANCER DRUGS
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- PAMAM-Camptothecin Conjugate Inhibits Proliferation and Induces Nuclear Fragmentation in Colorectal Carcinoma Cells
- (2010) Giridhar Thiagarajan et al. PHARMACEUTICAL RESEARCH
- Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice
- (2009) Fatemeh Atyabi et al. ACTA PHARMACEUTICA
- Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery
- (2009) Yasemin Çirpanli et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma
- (2009) P. Sapra et al. HAEMATOLOGICA
- Antibody Targeting of Camptothecin-Loaded PLGA Nanoparticles to Tumor Cells
- (2008) Paul A. McCarron et al. BIOCONJUGATE CHEMISTRY
- Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers
- (2008) Hong Zhao et al. BIOCONJUGATE CHEMISTRY
- Novel SN-38-Incorporated Polymeric Micelle, NK012, Strongly Suppresses Renal Cancer Progression
- (2008) M. Sumitomo et al. CANCER RESEARCH
- DTS-108, A Novel Peptidic Prodrug of SN38: In vivo Efficacy and Toxicokinetic Studies
- (2008) F. Meyer-Losic et al. CLINICAL CANCER RESEARCH
- Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model
- (2008) P. Sapra et al. CLINICAL CANCER RESEARCH
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
- (2008) H. Maeda et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer
- (2008) Sun Hwa Kim et al. JOURNAL OF CONTROLLED RELEASE
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Antibody Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN-38) for Targeted Cancer Chemotherapy
- (2008) Sung-Ju Moon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Docetaxel–Albumin Conjugates: Preparation, In Vitro Evaluation and Biodistribution Studies
- (2008) Farnaz Esmaeili et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
- Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
- (2008) Rohit B. Kolhatkar et al. PHARMACEUTICAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started